Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Serif Biomedicines is seeking a Scientist I to join the Analytical Development and Quality Control team in a fast-paced, entrepreneurial setting. The role focuses on building efficient systems for testing samples and delivering data, with method development for nucleic acid cargo and LNP delivery vehicles.
You will mentor colleagues, contribute to platform goals, and communicate results clearly in both oral and written formats, while maintaining rigorous records and SOPs within Benchling.
Serif Biomedicines is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.
Serif was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ:MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.
We are seeking a highly motivated and skilled candidate for a role of Scientist I on the Analytical Development and Quality Control team. This candidate will contribute to: building efficient system for testing samples and delivering the data; method development, optimization and qualification to support characterization of novel nucleic acid therapeutics and LNP delivery vehicles. We are looking for an individual who enjoys hands-on laboratory benchwork as well as mentoring other team members and brings scientific rigor and intellectual curiosity to their role. This individual will have the opportunity to work in a dynamic and fast-paced entrepreneurial environment as part of a highly collaborative and rapidly growing team.
We are creative optimists and we would love for you to consider joining our team! See all our open opportunities across Flagship Pioneering's Ecosystem!
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including: Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evel